Massimo Group financials

MAMO CIK 0001952853

Source: EDGAR filings · Built 2026-06-02T03:30:04Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2023
Free Cash Flow -209.96K 6.24M 10.73M 380.99K
EBITDA 2.12M 5.22M 13.12M 4.75M
Working Capital 17.59M 17.88M 19.53M 3.46M
Net Debt 1.66M -600.47K 1.13M 6.09M
Gross Margin 37.52% 29.69% 31.22% 25.66%
Operating Margin 2.76% 4.62% 11.23% 5.32%
Net Margin 2.10% 1.61% 9.05% 4.81%
Return on Equity (ROE) 6.37% 8.12% 71.89% 82.07%
Return on Assets (ROA) 2.93% 3.21% 24.83% 11.29%
Current Ratio 1.79× 1.69× 2.04× 1.11×
Debt-to-Equity 0.31× 0.44× 0.13× 1.39×
Effective Tax Rate 25.63% 27.09% 16.98%
Cash Conversion Ratio -0.07× 3.79× 1.05× 0.15×
Accruals Ratio 0.03× -0.09× -0.01× 0.10×
SBC % of Revenue 0.27% 0.21%
CapEx Coverage -0.88× 15.53× 62.44× 2.59×
Free Cash Flow Per Share $-0.01 $0.15 $0.27

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2023
P/E Trailing (Diluted) 99.50× 64.25×
P/FCF 16.94×
FCF Yield 5.90%
EV / EBITDA 78.90× 20.33×
P/S 2.31× 0.98×
P/B 6.99× 4.92×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2023
Revenue from Contract with Customer, Excluding Assessed Tax 71.83M 109.33M 115.04M 86.53M
Revenues 1.90M
Cost of Goods and Services Sold 44.88M 76.87M 79.13M 64.32M
Cost of Revenue 44.88M 76.87M
Gross Profit 26.95M 32.46M 35.91M 22.20M
Research and Development Expense 2.09M 343.49K
Operating Expenses 24.97M 27.41M 22.99M 17.60M
Operating Income (Loss) 1.98M 5.05M 12.92M 4.61M
Income Tax Expense (Benefit) 520.10K 654.76K 2.13M
Net Income (Loss) Attributable to Parent 1.51M 1.76M 10.42M 4.16M
Earnings Per Share, Basic $0.04 $0.04 $0.26
Weighted Average Number of Shares Outstanding, Basic 41.60M 41.01M 40.00M
Earnings Per Share, Diluted $0.04 $0.04 $0.26
Weighted Average Number of Shares Outstanding, Diluted 41.64M 41.16M 40.00M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2023
Cash and Cash Equivalents, at Carrying Value 5.79M 10.21M
Assets, Current 39.85M 43.62M 38.36M 34.59M
Assets 51.43M 54.89M 41.94M 36.86M
Liabilities, Current 22.25M 25.74M 18.83M 31.13M
Liabilities 27.72M 33.19M 27.46M 31.79M
Stockholders' Equity Attributable to Parent 23.71M 21.70M 14.49M 5.07M
Common Stock, Shares, Outstanding 41.64M 41.54M 40.00M 40.00M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2023
Net Cash Provided by (Used in) Operating Activities -98.28K 6.67M 10.91M 621.29K
Payments to Acquire Property, Plant, and Equipment 65.36K 387.88K 134.66K 197.80K
Net Cash Provided by (Used in) Investing Activities -731.03K -225.88K -121.16K -197.80K
Net Cash Provided by (Used in) Financing Activities -3.59M 3.00M -10.97M -764.37K

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MAMO CIK 0001952853), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

CRVS

Corvus Pharmaceuticals, Inc.

MDWD

MEDIWOUND LTD.

TSHA

Taysha Gene Therapies, Inc.